Endometriosis
Conditions
Interventions
The therapeutic level of blood E2 is 30-50pg/mL. Three menthes after start of 2 mg/day Dienogest treatment, we measure the serum E2 level. If that is less than 30pg/mL, 1 mg/day Dienogest treatment wi
Sponsors
Okayama University Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1)Women with Endometriosis. 2)Women without wish for pregnancy right now. 3)Women whose best therapy is drug treatment. 4)Women who are well imformed and consented to perticipate this study. 5)Outpatient.
Exclusion criteria
Exclusion criteria: 1)Women who hope pregnancy right now. 2)whomen who suspected with mallignancy desease. 3)Women who are considerd inadequate to perticipate this study by investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The possibility of management for endometriosis with the optimal dose of Dienogest witch decided from serum estradiol level. | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of the physical profile between the normal quantity optimum group and reduced quantity optimum group. | — |
Countries
Japan
Contacts
Public ContactYasuhiko Kamada
Okayama University Hospital Obstetrics and Gynecology
Outcome results
None listed